Cornelis M de Mooij

4PUBLICATIONS
3CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Sep 20, 2024
Disease extent according to baseline [18F]fluorodeoxyglucose PET/CT and molecular subtype: prediction of axillary treatment response after neoadjuvant systemic therapy for breast cancer.

Florien J G van Amstel, Cornelis M de Mooij, Janine M Simons

|Jan 23, 2023
The influence of receptor expression and clinical subtypes on baseline [18F]FDG uptake in breast cancer: systematic review and meta-analysis.

Cornelis M de Mooij, Roxanne A W Ploumen, Patty J Nelemans

|Jan 21, 2023
Prediction of Primary Tumour and Axillary Lymph Node Response to Neoadjuvant Chemo(Targeted) Therapy with Dedicated Breast [18F]FDG PET/MRI in Breast Cancer.

Cornelis M de Mooij, Thiemo J A van Nijnatten, Briete Goorts

|Nov 22, 2021
Value of 18F-FDG PET/CT for predicting axillary pathologic complete response following neoadjuvant systemic therapy in breast cancer patients: emphasis on breast cancer subtype.

Cornelis M de Mooij, Cristina Mitea, Felix M Mottaghy

Pageof 1

Frequent Collaborators

2 joint publications

Thiemo J A van Nijnatten

1 joint publications

Loes F S Kooreman

1 joint publications

Felix M Mottaghy